• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过深度突变扫描绘制人类抗HIV血清的中和特异性图谱。

Mapping the neutralizing specificity of human anti-HIV serum by deep mutational scanning.

作者信息

Radford Caelan E, Schommers Philipp, Gieselmann Lutz, Crawford Katharine H D, Dadonaite Bernadeta, Yu Timothy C, Dingens Adam S, Overbaugh Julie, Klein Florian, Bloom Jesse D

机构信息

Molecular and Cellular Biology Graduate Program, University of Washington, and Basic Sciences Division, Fred Hutch Cancer Center, Seattle, Washington, 98109, USA.

Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Center, Seattle, Washington, 98109, USA.

出版信息

bioRxiv. 2023 Mar 24:2023.03.23.533993. doi: 10.1101/2023.03.23.533993.

DOI:10.1101/2023.03.23.533993
PMID:36993197
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10055425/
Abstract

Understanding the specificities of human serum antibodies that broadly neutralize HIV can inform prevention and treatment strategies. Here we describe a deep mutational scanning system that can measure the effects of combinations of mutations to HIV envelope (Env) on neutralization by antibodies and polyclonal serum. We first show that this system can accurately map how all functionally tolerated mutations to Env affect neutralization by monoclonal antibodies. We then comprehensively map Env mutations that affect neutralization by a set of human polyclonal sera known to target the CD4-binding site that neutralize diverse strains of HIV. The neutralizing activities of these sera target different epitopes, with most sera having specificities reminiscent of individual characterized monoclonal antibodies, but one sera targeting two epitopes within the CD4 binding site. Mapping the specificity of the neutralizing activity in polyclonal human serum will aid in assessing anti-HIV immune responses to inform prevention strategies.

摘要

了解能广泛中和HIV的人血清抗体的特异性可为预防和治疗策略提供依据。在此,我们描述了一种深度突变扫描系统,该系统可测量HIV包膜(Env)突变组合对抗体和多克隆血清中和作用的影响。我们首先表明,该系统能够准确绘制出所有对Env功能耐受的突变如何影响单克隆抗体的中和作用。然后,我们全面绘制了Env突变,这些突变会影响一组已知靶向CD4结合位点以中和多种HIV毒株的人多克隆血清的中和作用。这些血清的中和活性靶向不同的表位,大多数血清具有类似于单个已表征单克隆抗体的特异性,但有一种血清靶向CD4结合位点内的两个表位。绘制多克隆人血清中中和活性的特异性将有助于评估抗HIV免疫反应,为预防策略提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/106d/10055425/c97b0b6e8755/nihpp-2023.03.23.533993v1-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/106d/10055425/fa4cfbfae5a8/nihpp-2023.03.23.533993v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/106d/10055425/90e89f6d1380/nihpp-2023.03.23.533993v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/106d/10055425/3a21cb76a974/nihpp-2023.03.23.533993v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/106d/10055425/6b610849fd47/nihpp-2023.03.23.533993v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/106d/10055425/c97b0b6e8755/nihpp-2023.03.23.533993v1-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/106d/10055425/fa4cfbfae5a8/nihpp-2023.03.23.533993v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/106d/10055425/90e89f6d1380/nihpp-2023.03.23.533993v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/106d/10055425/3a21cb76a974/nihpp-2023.03.23.533993v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/106d/10055425/6b610849fd47/nihpp-2023.03.23.533993v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/106d/10055425/c97b0b6e8755/nihpp-2023.03.23.533993v1-f0007.jpg

相似文献

1
Mapping the neutralizing specificity of human anti-HIV serum by deep mutational scanning.通过深度突变扫描绘制人类抗HIV血清的中和特异性图谱。
bioRxiv. 2023 Mar 24:2023.03.23.533993. doi: 10.1101/2023.03.23.533993.
2
Mapping the neutralizing specificity of human anti-HIV serum by deep mutational scanning.通过深度突变扫描绘制人抗 HIV 血清的中和特异性图谱。
Cell Host Microbe. 2023 Jul 12;31(7):1200-1215.e9. doi: 10.1016/j.chom.2023.05.025. Epub 2023 Jun 15.
3
High-resolution mapping of the neutralizing and binding specificities of polyclonal sera post-HIV Env trimer vaccination.HIV Env 三聚体疫苗接种后多克隆血清中和及结合特异性的高分辨率图谱绘制。
Elife. 2021 Jan 13;10:e64281. doi: 10.7554/eLife.64281.
4
Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals.对来自1型人类免疫缺陷病毒感染个体的多克隆血清中的中和特异性进行分析。
J Virol. 2009 Jan;83(2):1045-59. doi: 10.1128/JVI.01992-08. Epub 2008 Nov 12.
5
Evolution of cross-neutralizing antibody specificities to the CD4-BS and the carbohydrate cloak of the HIV Env in an HIV-1-infected subject.HIV-1 感染者体内针对 HIV Env 的 CD4-BS 和糖萼的交叉中和抗体特异性的演变。
PLoS One. 2012;7(11):e49610. doi: 10.1371/journal.pone.0049610. Epub 2012 Nov 13.
6
A facile method of mapping HIV-1 neutralizing epitopes using chemically masked cysteines and deep sequencing.一种使用化学掩蔽半胱氨酸和深度测序绘制 HIV-1 中和表位的简便方法。
Proc Natl Acad Sci U S A. 2020 Nov 24;117(47):29584-29594. doi: 10.1073/pnas.2010256117. Epub 2020 Nov 9.
7
Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.从一名感染HIV-1 C亚型的精英中和者体内获得的构象表位特异性广泛中和性血浆抗体通过V1环区的突变介导自体病毒逃逸。
J Virol. 2016 Jan 13;90(7):3446-57. doi: 10.1128/JVI.03090-15.
8
Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies.设计用于呈现CD4结合位点的高糖基化稳定核心免疫原优先被广泛中和抗体识别。
J Virol. 2014 Dec;88(24):14002-16. doi: 10.1128/JVI.02614-14. Epub 2014 Sep 24.
9
Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors.剖析来自1型人类免疫缺陷病毒感染供体的广泛中和血清的中和抗体特异性。
J Virol. 2007 Jun;81(12):6548-62. doi: 10.1128/JVI.02749-06. Epub 2007 Apr 4.
10
Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.多种重组HIV-1包膜蛋白无法激活表达广泛中和抗HIV-1抗体PG9和447-52D的种系B细胞受体的B细胞。
J Virol. 2014 Mar;88(5):2645-57. doi: 10.1128/JVI.03228-13. Epub 2013 Dec 18.

本文引用的文献

1
A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike.一种假病毒系统可实现对完整 SARS-CoV-2 刺突蛋白的深度突变扫描。
Cell. 2023 Mar 16;186(6):1263-1278.e20. doi: 10.1016/j.cell.2023.02.001. Epub 2023 Feb 13.
2
CD4 binding site immunogens elicit heterologous anti-HIV-1 neutralizing antibodies in transgenic and wild-type animals.CD4 结合位点免疫原在转基因和野生型动物中引发了针对 HIV-1 的异源中和抗体。
Sci Immunol. 2023 Feb 17;8(80):eade6364. doi: 10.1126/sciimmunol.ade6364. Epub 2023 Feb 10.
3
A biophysical model of viral escape from polyclonal antibodies.
病毒从多克隆抗体逃逸的生物物理模型。
Virus Evol. 2022 Dec 12;8(2):veac110. doi: 10.1093/ve/veac110. eCollection 2022.
4
Vaccination induces HIV broadly neutralizing antibody precursors in humans.接种疫苗可在人体内诱导产生 HIV 广谱中和抗体前体。
Science. 2022 Dec 2;378(6623):eadd6502. doi: 10.1126/science.add6502.
5
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies.诱导广泛中和抗体的 HIV-1 疫苗策略。
Nat Rev Immunol. 2023 Mar;23(3):142-158. doi: 10.1038/s41577-022-00753-w. Epub 2022 Aug 12.
6
Broadly neutralizing antibodies against HIV-1 and concepts for application.广谱中和抗体抗 HIV-1 及应用概念。
Curr Opin Virol. 2022 Jun;54:101211. doi: 10.1016/j.coviro.2022.101211. Epub 2022 Mar 17.
7
Structure-guided envelope trimer design in HIV-1 vaccine development: a narrative review.基于结构的 HIV-1 包膜三聚体疫苗设计:叙述性综述。
J Int AIDS Soc. 2021 Nov;24 Suppl 7(Suppl 7):e25797. doi: 10.1002/jia2.25797.
8
Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM.利用冷冻电镜解析 HIV Env 免疫原的多克隆抗体反应。
Nat Commun. 2021 Aug 10;12(1):4817. doi: 10.1038/s41467-021-25087-4.
9
HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens.HIV-1与新型冠状病毒:两种大流行病原体的进化模式
Cell Host Microbe. 2021 Jul 14;29(7):1093-1110. doi: 10.1016/j.chom.2021.05.012. Epub 2021 Jun 3.
10
Serotypic evolution of measles virus is constrained by multiple co-dominant B cell epitopes on its surface glycoproteins.麻疹病毒的血清型进化受到其表面糖蛋白上多个共显性 B 细胞表位的限制。
Cell Rep Med. 2021 Mar 30;2(4):100225. doi: 10.1016/j.xcrm.2021.100225. eCollection 2021 Apr 20.